AGP Executive Report
Last update: 11 hours agoFDA Pathway for Neurodegeneration: Alterity Therapeutics says FDA meeting minutes confirm a registrational path for ATH434 in multiple system atrophy, with a single pivotal Phase 3 trial plus confirmatory support and Phase 3 set to start by year-end 2026. Public Health & Safety: Doctors warn that drowning remains a leading killer for young children, urging faster rescue and resuscitation and highlighting higher risk for Black, American Indian and Alaska Native kids. Climate & Wildlife: Research finds San Joaquin kit foxes are finding refuge inside major California solar farms, where predator-proof fencing and panel cover reduce predation risk. Community Health in Boyle Heights: USC’s CLEAN project is offering free rapid-response soil testing after a long Lineage warehouse fire raised contamination concerns, while UCLA tests water and air monitoring continues. AI in Cybersecurity: CISA is reportedly using Anthropic’s Mythos to scan government code for security flaws, aiming to spot vulnerabilities before they’re exploited. Education/Admissions: UC faces renewed pressure to reinstate SAT/ACT for STEM applicants as professors argue test scores predict readiness for coursework. Tech/Markets: Intel-backed edge-AI chipmaker Syntiant files for a U.S. IPO, betting on low-power on-device AI demand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
